Stress hyperglycemia in pediatric critical illness: The intensive care unit adds to the stress!

Journal of Diabetes Science and Technology

Volumn 6, Issue 1, 2012, Pages 37-47

  Srinivasan, Vijay ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Blood glucose; Children; Critical illness; Stress hyperglycemia; Tight glucose control

Indexed keywords

GLUCOSE;

ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CHILDHOOD DISEASE; CONFERENCE PAPER; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; IMMOBILITY; INDUCED HYPOTHERMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTENSIVE CARE UNIT; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; RENAL REPLACEMENT THERAPY; STRESS; STRESS HYPERGLYCEMIA; TIGHT GLUCOSE CONTROL; ADULT; BIOLOGICAL MODEL; CHILD; EVALUATION; GLUCOSE BLOOD LEVEL; INTENSIVE CARE; METABOLISM; METHODOLOGY; MONITORING; ORGANIZATION AND MANAGEMENT; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

ADULT; BLOOD GLUCOSE; CHILD; CRITICAL CARE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; INTENSIVE CARE UNITS, PEDIATRIC; MODELS, BIOLOGICAL; MONITORING, PHYSIOLOGIC; STRESS, PHYSIOLOGICAL;

EID: 84863565804     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600106     Document Type: Conference Paper

References (104)

1. Srinivasan V, Spinella PC, Drott HR, Roth CL, Helfaer MA, Nadkarni V. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med. 2004;5(4):329-36.
2. Faustino EV, Apkon M. Persistent hyperglycemia in critically ill children. J Pediatr 2005;146(1):30-4. (Pubitemid 40091727)
3. Wintergerst KA, Buckingham B, Gandrud L, Wong BJ, Kache S, Wilson DM. Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics. 2006;118(1):173-9. (Pubitemid 46071160)
4. Yung M, Wilkins B, Norton L, Slater A; Paediatric Study Group; Australian and New Zealand Intensive Care Society. Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med. 2008;9(2):147-52. (Pubitemid 351355025)
5. Hirshberg E, Larsen G, Van Duker H. Alterations in glucose homeostasis in the pediatric intensive care unit: Hyperglycemia and glucose variability are associated with increased mortality and morbidity. Pediatr Crit Care Med. 2008;9(4):361-6.
6. Preissig CM, Rigby MR. Pediatric critical illness hyperglycemia: risk factors associated with development and severity of hyperglycemia in critically ill children. J Pediatr. 2009;155(5):734-9.
7. Ognibene KL, Vawdrey DK, Biagas KV. The association of age, illness severity, and glycemic status in a pediatric intensive care unit. Pediatr Crit Care Med. 2011;12(6):e386-90.
8. Weise K, Zaritsky A. Endocrine manifestations of critical illness in the child. Pediatr Clin North Am. 1987;34(1):119-30. (Pubitemid 17014571)
9. Gupta P, Natarajan G, Agarwal KN. Transient hyperglycemia in acute childhood illnesses: to attend or ignore? Indian J Pediatr. 1997;64(2):205-10. (Pubitemid 127510578)
10. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001;51(3):540-4. (Pubitemid 33009642)
11. Cochran A, Scaife ER, Hansen KW, Downey EC. Hyperglycemia and outcomes from pediatric traumatic brain injury. J Trauma. 2003;55(6):1035-8. (Pubitemid 38044117)
12. Michaud LJ, Rivara FP, Longstreth WT Jr, Grady MS. Elevated initial blood glucose levels and poor outcome following severe brain injuries in children. J Trauma. 1991;31(10):1356-62.
13. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatr Crit Care Med. 2005;6(4):470-2. (Pubitemid 40980830)
14. Yates AR, Dyke PC 2nd, Taeed R, Hoffman TM, Hayes J, Feltes TF, Cua CL. Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med. 2006;7(4):351-5. (Pubitemid 44048279)
15. Day KM, Haub N, Betts H, Inwald DP. Hyperglycemia is associated with morbidity in critically ill children with meningococcal sepsis. Pediatr Crit Care Med. 2008;9(6):636-40.
16. Tuggle DW, Kuhn MA, Jones SK, Garza JJ, Skinner S. Hyperglycemia and infections in pediatric trauma patients. Am Surg. 2008;74(3):195-8. (Pubitemid 351323696)
17. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359-67.
18. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449-61. (Pubitemid 43200296)
19. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhard K. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-39.
20. Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Wernerman J, Joannidis M, Stecher A, Chioléro R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35(10):1738-48.
21. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283-97.
22. Preiser JC. NICE-SUGAR: the end of a sweet dream? Crit Care. 2009;13(3):143.
23. Scurlock C, Raikhelkar J, Mechanick JI. Critique of normoglycemia in intensive care evaluation: survival using glucose algorithm regulation (NICE-SUGAR) - a review of recent literature. Curr Opin Clin Nutr Metab Care. 2010;13(2):211-4.
24. Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G. Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009;373(9663):547-56.
25. Hirshberg E, Lacroix J, Sward K, Willson D, Morris AH. Blood glucose control in critically ill adults and children: a survey on stated practice. Chest. 2008;133(6):1328-35. (Pubitemid 351892987)
26. Preissig CM, Rigby MR. A disparity between physician attitudes and practice regarding hyperglycemia in pediatric intensive care units in the United States: a survey on actual practice habits. Crit Care. 2010;14(1):R11.
27. Bhisitkul DM, Morrow AL, Vinik AI, Shults J, Layland JC, Rohn R. Prevalence of stress hyperglycemia among patients attending a pediatric emergency department. J Pediatr. 1994;124(4):547-51. (Pubitemid 24128149)
28. Valerio G, Franzese A, Carlin E, Pecile P, Perini R, Tenore A. High prevalence of stress hyperglycaemia in children with febrile seizures and traumatic injuries. Acta Paediatr. 2001;90(6):618-22. (Pubitemid 32595863)
29. Ulate KP, Lima Falcao GC, Bielefeld MR, Morales JM, Rotta AT. Strict glycemic targets need not be so strict: a more permissive glycemic range for critically ill children. Pediatrics. 2008;122(4):e898-904.
30. O'Brien JE Jr, Marshall JA, Tarrants ML, Stroup RE, Lofland GK. Intraoperative hyperglycemia and postoperative bacteremia in the pediatric cardiac surgery patient. Ann Thorac Surg. 2010;89(2):578-83.
31. Mechanick JI. Metabolic mechanisms of stress hyperglycemia. JPEN J Parenter Enteral Nutr. 2006;30(2):157-63. (Pubitemid 44314789)
32. Dufour S, Lebon V, Shulman GI, Petersen KF. Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans. Am J Physiol Endocrinol Metab. 2009;297(1):E231-5.
33. Kulp GA, Herndon DN, Lee JO, Suman OE, Jeschke MG. Extent and magnitude of catecholamine surge in pediatric burned patients. Shock. 2010;33(4):369-74.
34. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15(4):533-51.
35. Jeevanandam M, Young DH, Schiller WR. Glucose turnover, oxidation, and indices of recycling in severely traumatized patients. J Trauma. 1990;30(5):582-9. (Pubitemid 20194543)
36. Gebara BM, Gelmini M, Sarnaik A. Oxygen consumption, energy expenditure, and substrate utilization after cardiac surgery in children. Crit Care Med. 1992;20(11):1550-4.
37. Shamoon H, Hendler R, Sherwin RS. Synergistic interactions among antiinsulin hormones in the pathogenesis of stress hyperglycemia in humans. J Clin Endocrinol Metab. 1981;52(6):1235-41. (Pubitemid 13237531)
38. Stumvoll M, Chintalapudi U, Perriello G, Welle S, Gutierrez O, Gerich J. Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest. 1995;96(5):2528-33.
39. Gardelis JG, Hatzis TD, Stamogiannou LN, Dona AA, Fotinou AD, Brestas PS, Constantopoulos AG. Activity of the growth hormone/insulin-like growth factor-I axis in critically ill children. J Pediatr Endocrinol Metab. 2005;18(4):363-72. (Pubitemid 40520629)
40. Hunt DG, Ivy JL. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol. 2002;93(5):1638-43. (Pubitemid 36082974)
41. Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA. Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J. 1997;321(Pt 3):707-12. (Pubitemid 27084879)
42. Li L, Thompson LH, Zhao L, Messina JL. Tissue-specific difference in the molecular mechanisms for the development of acute insulin resistance after injury. Endocrinology. 2009;150(1):24-32.
43. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992-3002.
44. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ 3rd, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab. 2009;94(5):1656-64.
45. Preissig CM, Rigby MR. Hyperglycaemia results from beta-cell dysfunction in critically ill children with respiratory and cardiovascular failure: a prospective observational study. Crit Care. 2009;13(1):R27.
46. Van Waardenburg DA, Jansen TC, Vos GD, Buurman WA. Hyperglycemia in children with meningococcal sepsis and septic shock: the relation between plasma levels of insulin and inflammatory mediators. J Clin Endocrinol Metab. 2006;91(10):3916-21. (Pubitemid 44536864)
47. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest. 2004;114(9):1187-95.
48. Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, De Wolf-Peeters C, Van den Berghe G. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet. 2005;365(9453):53-9. (Pubitemid 40082146)
49. Vanhorebeek I, Gunst J, Derde S, Derese I, Boussemaere M, Güiza F, Martinet W, Timmermans JP, D'Hoore A, Wouters PJ, Van den Berghe G. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab. 2011;96(4):E633-45.
50. Turina M, Fry DE, Polk HC Jr. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med. 2005;33(7):1624-33. (Pubitemid 40980623)
51. Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. JPEN J Parenter Enteral Nutr. 1991;15(1):60-4.
52. Nareika A, Im YB, Game BA, Slate EH, Sanders JJ, London SD, Lopes-Virella MF, Huang Y. High glucose enhances lipopolysaccharide-stimulated CD14 expression in U937 mononuclear cells by increasing nuclear factor kappaB and AP-1 activities. J Endocrinol. 2008;196(1):45-55. (Pubitemid 351234570)
53. Aljada A, Friedman J, Ghanim H, Mohanty P, Hofmeyer D, Chaudhuri A, Dandona P. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism. 2006;55(9):1177-85. (Pubitemid 44215936)
54. Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115(8):2277-86. (Pubitemid 41134169)
55. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia- induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes. 1999;48(4):855-64. (Pubitemid 29153087)
56. Ellger B, Langouche L, Richir M, Debaveye Y, Vanhorebeek I, Teerlink T, Van Leeuwen PA, Van den Berghe G. Modulation of regional nitric oxide metabolism: blood glucose control or insulin? Intensive Care Med. 2008;34(8):1525-33.
57. Rao AK, Chouhan V, Chen X, Sun L, Boden G. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes. 1999;48(5):1156-61. (Pubitemid 29226365)
58. Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS. Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1999;282(1):54-61. (Pubitemid 29318933)
59. Baker EH, Wood DM, Brennan AL, Clark N, Baines DL, Philips BJ. Hyperglycaemia and pulmonary infection. Proc Nutr Soc. 2006;65(3):227-35. (Pubitemid 46323838)
60. Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876-91. (Pubitemid 47632264)
61. Cazzato S, Bernardi F, Salardi S, Tassinari D, Corsini I, Ragni L, Cicognani A, Cacciari E. Lung function in children with diabetes mellitus. Pediatr Pulmonol. 2004;37(1):17-23. (Pubitemid 38030065)
62. Milla CE, Warwick WJ, Moran A. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med. 2000;162(3 Pt 1):891-5.
63. Barth E, Albuszies G, Baumgart K, Matejovic M, Wachter U, Vogt J, Radermacher P, Calzia E. Glucose metabolism and catecholamines. Crit Care Med. 2007;35(9 Suppl):S508-18. (Pubitemid 47312187)
64. Goldstein SL. Advances in pediatric renal replacement therapy for acute kidney injury. Semin Dial. 2011;24(2):187-91.
65. Selby NM, Fialova J, Burton JO, McIntyre CW. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid-based peritoneal dialysis fluids. Nephrol Dial Transplant. 2007;22(3):870-9. (Pubitemid 46351699)
66. Gunst J, Schetz M. Clinical benefits of tight glycaemic control: effect on the kidney. Best Pract Res Clin Anaesthesiol. 2009;23(4):431-9.
67. Kansagara D, Fu R, Freeman M, Wolf F, Helfand M. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154(4):268-82.
68. Verhoeven JJ, Hokken-Koelega AC, den Brinker M, Hop WC, van Thiel RJ, Bogers AJ, Helbing WA, Joosten KF. Disturbance of glucose homeostasis after pediatric cardiac surgery. Pediatr Cardiol. 2011;32(2):131-8.
69. Falcao G, Ulate K, Kouzekanani K, Bielefeld MR, Morales JM, Rotta AT. Impact of postoperative hyperglycemia following surgical repair of congenital cardiac defects. Pediatr Cardiol. 2008;29(3):628-36.
70. Polito A, Thiagarajan RR, Laussen PC, Gauvreau K, Agus MS, Scheurer MA, Pigula FA, Costello JM. Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation. 2008;118(22):2235-42.
71. Ballweg JA, Wernovsky G, Ittenbach RF, Bernbaum J, Gerdes M, Gallagher PR, Dominguez TE, Zackai E, Clancy RR, Nicolson SC, Spray TL, Gaynor JW. Hyperglycemia after infant cardiac surgery does not adversely impact neurodevelopmental outcome. Ann Thorac Surg. 2007;84(6):2052-8. (Pubitemid 350122435)
72. Ballweg JA, Ittenbach RF, Bernbaum J, Gerdes M, Dominguez TE, Zackai EH, Clancy RR, Gaynor JW. Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology. Eur J Cardiothorac Surg. 2009;36(4):688-93.
73. De Ferranti S, Gauvreau K, Hickey PR, Jonas RA, Wypij D, du Plessis A, Bellinger DC, Kuban K, Newburger JW, Laussen PC. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology. 2004;100(6):1345-52. (Pubitemid 38679302)
74. Arrich J, Holzer M, Herkner H, Müllner M. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation. Cochrane Database Syst Rev. 2009;(4):CD004128.
75. Polderman KH. Mechanisms of action, physiological effects, and complications of hypothermia. Crit Care Med. 2009;37(7 Suppl):S186-202.
76. Nielsen N, Sunde K, Hovdenes J, Riker RR, Rubertsson S, Stammet P, Nilsson F, Friberg H; Hypothermia Network. Adverse events and their relation to mortality in out-of-hospital cardiac arrest patients treated with therapeutic hypothermia. Crit Care Med. 2011;39(1):57-64.
77. Brower RG. Consequences of bed rest. Crit Care Med. 2009;37(10 Suppl):S422-8.
78. Stuart CA, Shangraw RE, Prince MJ, Peters EJ, Wolfe RR. Bed-rest-induced insulin resistance occurs primarily in muscle. Metabolism. 1988;37(8):802-6.
79. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348-53. (Pubitemid 40570499)
80. Williams S, Horrocks IA, Ouvrier RA, Gillis J, Ryan MM. Critical illness polyneuropathy and myopathy in pediatric intensive care: A review. Pediatr Crit Care Med. 2007;8(1):18-22. (Pubitemid 46168352)
81. Bier DM, Leake RD, Haymond MW, Arnold KJ, Gruenke LD, Sperling MA, Kipnis DM. Measurement of "true" glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes. 1977;26(11):1016-23. (Pubitemid 8229933)
82. Sheridan RL, Yu YM, Prelack K, Young VR, Burke JF, Tompkins RG. Maximal parenteral glucose oxidation in hypermetabolic young children: a stable isotope study. JPEN J Parenter Enteral Nutr. 1998;22(4):212-6. (Pubitemid 28307583)
83. Verbruggen SC, de Betue CT, Schierbeek H, Chacko S, van Adrichem LN, Verhoeven J, van Goudoever JB, Joosten KF. Reducing glucose infusion safely prevents hyperglycemia in post-surgical children. Clin Nutr. 2011;30(6):786-92.
84. Lienhardt A, Rakotoambinina B, Colomb V, Souissi S, Sadoun E, Goulet O, Robert JJ, Ricour C. Insulin secretion and sensitivity in children on cyclic total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1998;22(6):382-6. (Pubitemid 28520515)
85. Hart DW, Wolf SE, Zhang XJ, Chinkes DL, Buffalo MC, Matin SI, DebRoy MA, Wolfe RR, Herndon DN. Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med. 2001;29(7):1318-24. (Pubitemid 32641791)
86. Chwals WJ. Overfeeding the critically ill child: fact or fantasy? New Horiz. 1994;2(2):147-55.
87. Coss-Bu JA, Jefferson LS, Walding D, David Y, Smith EO, Klish WJ. Resting energy expenditure in children in a pediatric intensive care unit: comparison of Harris-Benedict and Talbot predictions with indirect calorimetry values. Am J Clin Nutr. 1998;67(1):74-80. (Pubitemid 28037628)
88. Framson CM, LeLeiko NS, Dallal GE, Roubenoff R, Snelling LK, Dwyer JT. Energy expenditure in critically ill children. Pediatr Crit Care Med. 2007;8(3):264-7. (Pubitemid 46743737)
89. Mehta NM, Bechard LJ, Dolan M, Ariagno K, Jiang H, Duggan C. Energy imbalance and the risk of overfeeding in critically ill children. Pediatr Crit Care Med. 2011;12(4):398-405.
90. Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, Acosta J, Herrero I, Palacios V, Lopez J, Blesa A, Martínez P; Metabolism, Nutrition Working Group, SEMICYUC, Spain. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med. 2011;39(6):1263-8.
91. Ahrens CL, Barletta JF, Kanji S, Tyburski JG, Wilson RF, Janisse JJ, Devlin JW. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit Care Med. 2005;33(11):2507-12. (Pubitemid 41682102)
92. Hebbard GS, Sun WM, Dent J, Horowitz M. Hyperglycaemia affects proximal gastric motor and sensory function in normal subjects. Eur J Gastroenterol Hepatol. 1996;8(3):211-7. (Pubitemid 26132096)
93. Petrakis IE, Kogerakis N, Prokopakis G, Zacharioudakis G, Antonakakis S, Vrachassotakis N, Chalkiadakis G. Hyperglycemia attenuates erythromycin-induced acceleration of liquid-phase gastric emptying of hypertonic liquids in healthy subjects. Dig Dis Sci. 2002;47(1):67-72. (Pubitemid 34075019)
94. Nguyen N, Ching K, Fraser R, Chapman M, Holloway R. The relationship between blood glucose control and intolerance to enteral feeding during critical illness. Intensive Care Med. 2007;33(12):2085-92. (Pubitemid 350164568)
95. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med. 2002;30(11):2438-42. (Pubitemid 35351860)
96. Kovár J, Fejfarová V, Pelikánová T, Poledne R. Hyperglycemia downregulates total lipoprotein lipase activity in humans. Physiol Res. 2004;53(1):61-8. (Pubitemid 38295542)
97. Zimmerman JJ. A history of adjunctive glucocorticoid treatment for pediatric sepsis: moving beyond steroid pulp fiction toward evidence-based medicine. Pediatr Crit Care Med. 2007;8(6):530-9. (Pubitemid 350076458)
98. Thomas Z, Bandali F, McCowen K, Malhotra A. Drug-induced endocrine disorders in the intensive care unit. Crit Care Med. 2010;38(6 Suppl):S219-30.
99. Luna B, Feinglos MN. Drug-induced hyperglycemia. JAMA. 2001;286(16):1945-8. (Pubitemid 33010204)
100. Beardsall K, Vanhaesebrouck S, Ogilvy-Stuart AL, Vanhole C, Palmer CR, van Weissenbruch M, Midgley P, Thompson M, Thio M, Cornette L, Ossuetta I, Iglesias I, Theyskens C, de Jong M, Ahluwalia JS, de Zegher F, Dunger DB. Early insulin therapy in very-low-birth-weight infants. N Engl J Med. 2008;359(18):1873-84.
101. Macrae D, Pappachan J, Grieve R, Parslow R, Nadel S, Schindler M, Baines P, Forne PM, Slavik Z, Goldman A, Truesdale A, Betts H, Allen E, Snowdon C, Percy D, Broadhead M, Quick T, Peters M, Morris K, Tasker R, Elbourne D. Control of hyperglycaemia in paediatric intensive care (CHiP): study protocol. BMC Pediatr. 2010;10:5.
102. National Heart, Lung, and Blood Institute (NHLBI). SPECS: Safe Pediatric Euglycemia in Cardiac Surgery. In: ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Available from: http://clinicaltrials.gov/ct2/show/ NCT00443599. Accessed on December 5, 2011.
103. Emory University. Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial. In: ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Available from: http://clinicaltrials.gov/ct2/show/NCT01116752?term=NCT01116752&rank= 1. Accessed on December 5, 2011.
104. Srinivasan, Vijay (Department of Anesthesiology and Critical Care Medicine, Children's Hospital of Philadelphia, Philadelphia, PA). Conversation with: Michael Agus (Children's Hospital Boston, Boston, MA). 2011.